Word

Status

Pending

Status Code

661

Status Date

Thursday, August 22, 2024

Serial Number

79378834

Mark Type

2

Filing Date

Thursday, May 4, 2023

Trademark Owner History

BRISTAR IMMUNOTECH LIMITED

Classifications

5 medicines for human purposes for the treatment of cancer, hematological tumors, solid tumors, autoimmune diseases, and regulation of the immune system; pharmaceutical preparations for the treatment of cancer, hematological tumors, solid tumors, autoimmune diseases, and regulation of the immune system; drugs for medical purposes, namely, medicines for the treatment of cancer, hematological tumors, solid tumors, autoimmune diseases, and regulation of the immune system; blood for medical purposes; biological preparations for medical purposes for the treatment of cancer, hematological tumors, solid tumors, autoimmune diseases, and regulation of the immune system; stem cells for medical purposes; immunostimulants; injectable medicinal solutions, namely, medicinal preparations for the treatment of cancer, tumors, autoimmune diseases, and regulation of the immune system; biochemical medicines for the treatment of cancer, tumors, autoimmune diseases, and regulation of the immune system; Blood products, namely, blood plasma

35 Import-export agency services; marketing; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale store services featuring medicines; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring sanitary preparations; retail and wholesale store services featuring medical supplies

44 T-cell treatment therapy services; blood bank services; human tissue bank services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; hospital services; medical clinic services; medical assistance; telemedicine services; nursing, medical; health care

42 Technological research in the field of evaluation of efficiency and safety of medication; conducting technical project studies in the field of evaluation of efficiency and safety of medication; scientific laboratory services; scientific research; chemical analysis; chemical research; biochemical research and analysis; medical and scientific research, namely, conducting clinical trials for others; biological research

The mark consists of a design of a circle containing three shaded circles, two oblongs and a quadrilateral.

Trademark Events

Sep 14, 2023

Sn Assigned For Sect 66a Appl From Ib

Sep 19, 2023

New Application Office Supplied Data Entered

Sep 23, 2023

Application Filing Receipt Mailed

Jan 30, 2024

Assigned To Examiner

Mar 19, 2024

Refusal Processed By Ib

Feb 6, 2024

Non-Final Action Written

Feb 7, 2024

Non-Final Action (Ib Refusal) Prepared For Review

Feb 28, 2024

Refusal Processed By Mpu

Feb 28, 2024

Non-Final Action Mailed - Refusal Sent To Ib

Aug 21, 2024

Correspondence Received In Law Office

Aug 21, 2024

Teas Response To Office Action Received

Aug 22, 2024

Teas/Email Correspondence Entered